Morgan Stanley Maintains Equal-Weight on CME Gr, Raises Price Target to $211
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Mike Cyprys has maintained an Equal-Weight rating on CME Group (NASDAQ:CME) and raised the price target from $210 to $211.
July 27, 2023 | 4:03 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley has maintained an Equal-Weight rating on CME Group and raised the price target from $210 to $211.
The news is directly related to CME Group as Morgan Stanley has maintained an Equal-Weight rating on the company and raised the price target. This could potentially influence investors' decisions, but the impact on the stock price is uncertain as the price target increase is minimal.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100